[CYCC] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 36.65%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 150 0 843 1,944 1,734 -
PBT -9,681 -9,125 -8,625 -8,463 -13,774 -16,486 -22,649 -13.19%
Tax -1,236 -1,297 -1,337 -993 -1,983 -2,144 -3,243 -14.83%
NP -8,445 -7,828 -7,288 -7,470 -11,791 -14,342 -19,387 -12.92%
Tax Rate - - - - - - - -
Total Cost 8,445 7,828 7,438 7,470 12,634 16,286 21,121 -14.15%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 -4,858.67 0.00 -1,398.70 -737.76 -1,118.05 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -34.86 -143.88 -12.05 -19.58 -68.85 -105.72 -211.93 -25.95%
EPS Diluted -34.86 -143.88 -12.05 -19.58 -68.85 -105.72 -211.93 -25.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.